The life sciences and healthcare sector faces mounting challenges from an ageing population and complex medication delivery. Key trends include rapid drug development and the digitisation of healthcare through connected devices. End-to-end digital platforms enable faster, compliant processes, reducing time to market for drugs and devices while ensuring efficiency and regulatory adherence.